Cholestasis in HIV-infected patients

Clinics in Liver Disease

Volumn 8, Issue 1, 2004, Pages 213-228

  Te, Helen S ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; ETHAMBUTOL; FLUCONAZOLE; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; MACROLIDE; NEVIRAPINE; PENTAMIDINE; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ABDOMINAL PAIN; ACALCULOUS CHOLECYSTITIS; BACTERIAL INFECTION; BARTONELLA HENSELAE; BILIARY TRACT DISEASE; CANCER CHEMOTHERAPY; CHOLESTASIS; COCCIDIOIDES IMMITIS; COMORBIDITY; CRYPTOCOCCUS NEOFORMANS; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EOSINOPHILIA; EXFOLIATIVE DERMATITIS; FEVER; HEMOLYTIC ANEMIA; HEPATITIS; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; KAPOSI SARCOMA; LEUKOCYTOSIS; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; LYMPHOMA; MALAISE; METHEMOGLOBINEMIA; MITOCHONDRIAL TOXICITY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEOPLASM; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRURITUS; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SPOROTHRIX SCHENCKII; STAGING; TREATMENT OUTCOME; TUBERCULOSIS; VOMITING;

CHOLESTASIS; HIV INFECTIONS; HUMANS; INFECTION; NEOPLASMS; PHARMACEUTICAL PREPARATIONS;

EID: 1642364917     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00129-6     Document Type: Review

References (72)

1. Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med. 92(4):1992;404-411.
2. Gordon S.C., Reddy K.R., Gould E.E., McFadden R., O'Brien C., De Medina M.et al. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol. 2(3):1986;475-484.
3. Payne T.H., Cohn D.L., Davidson A.J., Henry T.D., Schaefer J.W., Gabow P.A. Marked elevations of serum alkaline phosphatase in patients with AIDS. J Acquir Immune Defic Syndr. 4(3):1991;238-243.
4. Chalasani N., Wilcox C.M. Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome. Hepatology. 23(4):1996;728-733.
5. Reisler K. High hepatotoxicity rate seen among HAART patients. Aids Alert. 16(9):2001;118-119.
6. Wit F.W., Weverling G.J., Weel J., Jurriaans S., Lange J.M. Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis. 186(1):2002;23-31.
7. Sulkowski M.S., Thomas D.L., Chaisson R.E., Moore R.D. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 283(1):2000;74-80.
8. Spengler U., Lichterfeld M., Rockstroh J.K. Antiretroviral drug toxicity-a challenge for the hepatologist? J Hepatol. 36(2):2002;283-294.
9. Clark S.J., Creighton S., Portmann B., Taylor C., Wendon J.A., Cramp M.E. Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol. 36(2):2002;295-301.
10. Kakuda T.N. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 22(6):2000;685-708.
11. Kemmer M.J., Molina C.P., Fuchs J.E., Miskovsky E.P., Asmuth D.M., Borucki M.J.et al. A distinctive histologic pattern of liver injury in HIV-positive patients on HAART: a possible hepatotoxic effect of protease inhibitors. Hepatology. 32:2000;312A.
12. Sulkowski M.S., Thomas D.L., Mehta S.H., Chaisson R.E., Moore R.D. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology. 35(1):2002;182-189.
13. Gisolf E.H., Dreezen C., Danner S.A., Weel J.L., Weverling G.J. Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group. Clin Infect Dis. 31(5):2000;1234-1239.
14. Nunez M., Lana R., Mendoza J.L., Martin-Carbonero L., Soriano V. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 27(5):2001;426-431.
15. Dautzenberg B., Saint Marc T., Meyohas M.C., Eliaszewitch M., Haniez F., Rogues A.M.et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 153(3):1993;368-372.
16. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med. 91(3A):1991;40S-45S.
17. Westphal J.F., Vetter D., Brogard J.M. Hepatic side-effects of antibiotics. J Antimicrob Chemother. 33(3):1994;387-401.
18. Ransohoff D.F., Jacobs G. Terminal hepatic failure following a small dose of sulfamethoxazole- trimethoprim. Gastroenterology. 80(4):1981;816-819.
19. Kowdley K.V., Keeffe E.B., Fawaz K.A. Prolonged cholestasis due to trimethoprim sulfamethoxazole. Gastroenterology. 102(6):1992;2148-2150.
20. Gordin F.M., Simon G.L., Wofsy C.B., Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 100(4):1984;495-499.
21. Chalasani P., Baffoe-Bonnie H., Jurado R.L. Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. South Med J. 87(11):1994;1145-1146.
22. Orenstein R., Tsogas N. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection. Pharmacotherapy. 22(11):2002;1468-1478.
23. Ungo J.R., Jones D., Ashkin D., Hollender E.S., Bernstein D., Albanese A.P.et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med. 157(6 Pt 1):1998;1871-1876.
24. Danan G., Pessayre D., Larrey D., Benhamou J.P. Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again. Lancet. 2(8254):1981;1056-1057.
25. Slater L.N., Welch D.F., Min K.W. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med. 152(3):1992;602-606.
26. Cotell S.L., Noskin G.A. Bacillary angiomatosis. Clinical and histologic features, diagnosis, and treatment. Arch Intern Med. 154(5):1994;524-528.
27. Schneiderman D.J., Cello J.P., Laing F.C. Papillary stenosis and sclerosing cholangitis in the acquired immunodeficiency syndrome. Ann Intern Med. 106(4):1987;546-549.
28. Cappell M.S., Schwartz M.S., Biempica L. Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med. 88(2):1990;123-130.
29. Kahn S.A., Saltzman B.R., Klein R.S., Mahadevia P.S., Friedland G.H., Brandt L.J. Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study. Am J Gastroenterol. 81(12):1986;1145-1148.
30. Flegg P.J., Laing R.B., Lee C., Harris G., Watt B., Leen C.L.et al. Disseminated disease due to Mycobacterium avium complex in AIDS. QJM. 88(9):1995;617-626.
31. Glasgow B.J., Anders K., Layfield L.J., Steinsapir K.D., Gitnick G.L., Lewin K.J. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol. 83(5):1985;582-588.
32. Cappell M.S. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol. 86(1):1991;1-15.
33. Johnson P.C., Khardori N., Najjar A.F., Butt F., Mansell P.W., Sarosi G.A. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med. 85(2):1988;152-158.
34. Simonart T., Hermans P., Van Vooren J.P. Human herpesvirus 8 investigations: a role in the clinical management of Kaposi's sarcoma? Dermatology. 205(4):2002;340-343.
35. Ablashi D.V., Chatlynne L.G., Whitman J.E. Jr., Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev. 15(3):2002;439-464.
36. Friedman S.L. Gastrointestinal and hepatobiliary neoplasms in AIDS. Gastroenterol Clin N Am. 17(3):1988;465-486.
37. Bach N., Theise N.D., Schaffner F. Hepatic histopathology in the acquired immunodeficiency syndrome. Semin Liver Dis. 12(2):1992;205-212.
38. Friedman S.L., Wright T.L., Altman D.F. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology. 89(1):1985;102-108.
39. Hasan F.A., Jeffers L.J., Welsh S.W., Reddy K.R., Schiff E.R. Hepatic involvement as the primary manifestation of Kaposi's sarcoma in the acquired immune deficiency syndrome. Am J Gastroenterol. 84(11):1989;1449-1451.
40. Schneiderman D.J., Arenson D.M., Cello J.P., Margaretten W., Weber T.E. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology. 7(5):1987;925-930.
41. Schneiderman D.J. Hepatobiliary abnormalities of AIDS. Gastroenterol Clin N Am. 17(3):1988;615-630.
42. Lefkowitch J.H. Pathology of AIDS-related liver disease. Dig Dis. 12(6):1994;321-330.
43. Mitsuyasu R.T. Kaposi's sarcoma in the acquired immunodeficiency syndrome. Infect Dis Clin N Am. 2(2):1988;511-523.
44. Guarda L.A., Luna M.A., Smith J.L. Jr., Mansell P.W., Gyorkey F., Roca A.N. Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol. 81(5):1984;549-557.
45. Carrieri M.P., Pradier C., Piselli P., Piche M., Rosenthal E., Heudier P.et al. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 103(1):2003;142-144.
46. Herndier B.G., Friedman S.L. Neoplasms of the gastrointestinal tract and hepatobiliary system in acquired immunodeficiency syndrome. Semin Liver Dis. 12(2):1992;128-141.
47. Caccamo D., Pervez N.K., Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 110(6):1986;553-555.
48. Scerpella E.G., Villareal A.A., Casanova P.F., Moreno J.N. Primary lymphoma of the liver in AIDS. Report of one new case and review of the literature. J Clin Gastroenterol. 22(1):1996;51-53.
49. Rizzi E.B., Schinina V., Cristofaro M., David V., Bibbolino C. Non-hodgkin's lymphoma of the liver in patients with AIDS: sonographic, CT, and MRI findings. J Clin Ultrasound. 29(3):2001;125-129.
50. Ziegler J.L., Beckstead J.A., Volberding P.A., Abrams D.I., Levine A.M., Lukes R.J.et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 311(9):1984;565-570.
51. Straus D.J., Huang J., Testa M.A., Levine A.M., Kaplan L.D. Prognostic factors in the treatment of human immunodeficiency virus- associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol. 16(11):1998;3601-3606.
52. Vakil N.B., Schwartz S.M., Buggy B.P., Brummitt C.F., Kherellah M., Letzer D.M.et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med. 334(1):1996;19-23.
53. Teixidor H.S., Godwin T.A., Ramirez E.A. Cryptosporidiosis of the biliary tract in AIDS. Radiology. 180(1):1991;51-56.
54. Adolph M.D., Bass S.N., Lee S.K., Blum J.M., Schreiber H. Cytomegaloviral acalculous cholecystitis in acquired immunodeficiency syndrome patients. Am Surg. 59(10):1993;679-684.
55. Kavin H., Jonas R.B., Chowdhury L., Kabins S. Acalculous cholecystitis and cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med. 104(1):1986;53-54.
56. Wind P., Chevallier J.M., Jones D., Frileux P., Cugnenc P.H. Cholecystectomy for cholecystitis in patients with acquired immune deficiency syndrome. Am J Surg. 168(3):1994;244-246.
57. Pitlik S.D., Fainstein V., Rios A., Guarda L., Mansell P.W., Hersh E.M. Cryptosporidial cholecystitis. N Engl J Med. 308(6):1983;967.
58. French A.L., Beaudet L.M., Benator D.A., Levy C.S., Kass M., Orenstein J.M. Cholecystectomy in patients with AIDS: clinicopathologic correlations in 107 cases. Clin Infect Dis. 21(4):1995;852-858.
59. Fantry L.E., Sun C.C. Mycobacterium avium complex-associated cholecystitis in an HIV-infected woman. AIDS Patient Care STDS. 16(5):2002;201-204.
60. Zar F.A., El-Bayoumi E., Yungbluth M.M. Histologic proof of acalculous cholecystitis due to Cyclospora cayetanensis. Clin Infect Dis. 33(12):2001;E140-E141.
61. Benator D.A., French A.L., Beaudet L.M., Levy C.S., Orenstein J.M. Isospora belli infection associated with acalculous cholecystitis in a patient with AIDS. Ann Intern Med. 121(9):1994;663-664.
62. Margulis S.J., Honig C.L., Soave R., Govoni A.F., Mouradian J.A., Jacobson I.M. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med. 105(2):1986;207-210.
63. Cello J.P. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med. 86(5):1989;539-546.
64. Pol S., Romana C.A., Richard S., Amouyal P., Desportes-Livage I., Carnot F.et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med. 328(2):1993;95-99.
65. Benhamou Y., Caumes E., Gerosa Y., Cadranel J.F., Dohin E., Katlama C.et al. AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients. Dig Dis Sci. 38(6):1993;1113-1118.
66. Ducreux M., Buffet C., Lamy P., Beaugerie L., Fritsch J., Choury A.et al. Diagnosis and prognosis of AIDS-related cholangitis. Aids. 9(8):1995;875-880.
67. Bouche H., Housset C., Dumont J.L., Carnot F., Menu Y., Aveline B.et al. AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol. 17(1):1993;34-39.
68. Forbes A., Blanshard C., Gazzard B. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut. 34(1):1993;116-121.
69. Cello J.P., Chan M.F. Long-term follow-up of endoscopic retrograde cholangiopancreatography sphincterotomy for patients with acquired immune deficiency syndrome papillary stenosis. Am J Med. 99(6):1995;600-603.
70. Hamour A.A., Bonnington A., Hawthorne B., Wilkins E.G. Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. Aids. 711:1993;1449-1451.
71. Collazos J., Mayo J., Martinez E., Callejo A., Blanco I. Celiac plexus block as treatment for refractory pain related to sclerosing cholangitis in AIDS patients. J Clin Gastroenterol. 231:1996;47-49.
72. Castiella A., Iribarren J.A., Lopez P., Arrizabalaga J., Rodriguez F., von Wichmann M.A.et al. Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy. Am J Med. 103(2):1997;170-171.